These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 23386004

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC, Baracat EI, Massarollo PC, Pereira LA, Szutan LA.
    Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
    [Abstract] [Full Text] [Related]

  • 4. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG, de Medeiros Fleck A, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.
    Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
    [Abstract] [Full Text] [Related]

  • 5. THE OPTIMUM LEVEL OF MELD TO MINIMIZE THE MORTALITY ON LIVER TRANSPLANTATION WAITING LIST, AND LIVER TRANSPLANTED PATIENT IN SÃO PAULO STATE, BRAZIL.
    Chaib E, Pessoa JLE, Struchiner CJ, D'Albuquerque LAC, Massad E.
    Arq Bras Cir Dig; 2023; 36():e1746. PubMed ID: 37729279
    [Abstract] [Full Text] [Related]

  • 6. Increasing the donor pool reduces the severity of liver disease: lessons learned from São Paulo, Brazil.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2286-8. PubMed ID: 23026575
    [Abstract] [Full Text] [Related]

  • 7. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J, Kim DG, Lee JY, Lee JG, Joo DJ, Kim SI, Kim MS.
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
    Genda T, Ichida T, Sakisaka S, Sata M, Tanaka E, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y.
    J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939
    [Abstract] [Full Text] [Related]

  • 10. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M, Lai Q, Sessa M, Ghinolfi D, Fallani G, Patrono D, Di Sandro S, Avolio A, Odaldi F, Bronzoni J, Tandoi F, De Carlis R, Pascale MM, Mennini G, Germinario G, Rossi M, Agnes S, De Carlis L, Cescon M, Romagnoli R, De Simone P.
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [Abstract] [Full Text] [Related]

  • 11. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA, Polak WG, Porte RJ, van Hoek B, van den Berg AP, Metselaar HJ, IJzermans JNM.
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of the MELD allocation after its implementation in liver transplantation.
    Benckert C, Quante M, Thelen A, Bartels M, Laudi S, Berg T, Kaisers U, Jonas S.
    Scand J Gastroenterol; 2011 Jul; 46(7-8):941-8. PubMed ID: 21443420
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP, Pereyra D, Rumpf B, Hackl H, Köditz C, Ortmayr G, Reiberger T, Trauner M, Berlakovich GA, Starlinger P.
    Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
    [Abstract] [Full Text] [Related]

  • 16. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG, Villamil FG, Lendoire JC, Tagliafichi V, Lopez A, Krogh DH, Soratti CA, Bisigniano L.
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [Abstract] [Full Text] [Related]

  • 17. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ, Lai JC, Dodge JL, Roberts JP.
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [Abstract] [Full Text] [Related]

  • 18. Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list.
    Magder LS, Regev A, Mindikoglu AL.
    Transpl Int; 2012 Apr; 25(4):409-15. PubMed ID: 22299756
    [Abstract] [Full Text] [Related]

  • 19. Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant.
    Herden U, Grabhorn E, Briem-Richter A, Ganschow R, Nashan B, Fischer L.
    Clin Transplant; 2014 Sep; 28(9):1061-8. PubMed ID: 25040668
    [Abstract] [Full Text] [Related]

  • 20. Clinical epidemiological analysis of the mortality rate of liver transplant candidates living in rural areas.
    Molinari M, Renfrew PD, Petrie NM, De Coutere S, Abdolell M.
    Transpl Int; 2011 Mar; 24(3):292-9. PubMed ID: 21143650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.